Takeda

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Tokyo, with a global hub in Massachusetts, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.

In Singapore, Takeda comprises of a Growth & Emerging Markets (GEM) Business Unit which oversees almost 50 geographies, and two geographical operations with hubs to India & Southeast Asia (I-SEA) and Taiwan, Australia & South Korea (TAS) multi-country organizations. Our Takeda Development Centre Asia site, and a manufacturing site in Woodlands are headquartered in Singapore too.